Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab-Reference-Cited by-同舟云学术

Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab

Published:2021-09 Issue:5 Volume:22 Page:401-410
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Shintani Takashi,Kishi Noriko^ORCID,Matsuo Yukinori,Ogura Masakazu,Mitsuyoshi Takamasa,Araki Norio,Fujii Kota,Okumura Setsuko,Nakamatsu Kiyoshi,Kishi Takahiro,Atsuta Tomoko,Sakamoto Takashi,Narabayashi Masaru,Ishida Yuichi^ORCID,Sakamoto Masato,Fujishiro Satsuki,Katagiri Tomohiro^ORCID,Kim Young Hak,Mizowaki Takashi^ORCID

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference34 articles.

1. Radiation-induced lung injury;Hanania;Chest,2019

2. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105;Yamamoto;J Clin Oncol,2010

3. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007;Segawa;J Clin Oncol,2010

4. PROCLAIM: randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer;Senan;J Clin Oncol,2016

5. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG Oncology RTOG 0617 randomized clinical trial;Chun;J Clin Oncol,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer;Cancers;2024-09-11

2. Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer;Scientific Reports;2024-08-23

3. Pneumonitis Risk After Chemoradiotherapy With and Without Immunotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

4. Radiation-induced lung injury in malignant thoracic neoplasms: current state of the problem, trends in prevention and rehabilitation;PULMONOLOGIYA;2024-06-14

5. Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy;Journal of the National Cancer Center;2024-06